| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRM3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | LETM1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CLEC16A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SLIRP | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | MTERF2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | NUMB | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | TBC1D30 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TTC27 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PAK1IP1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | MPV17L | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
